Anagenics Limited (ASX:AN1)

Market Cap	5.91M +197.8%
Revenue (ttm)	5.16M +0.8%
Net Income	308.47K
EPS	0.00
Shares Out	985.45M
PE Ratio	15.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	375,160
Open	0.0060
Previous Close	0.0060
Day's Range	0.0060 - 0.0060
52-Week Range	0.0040 - 0.0090
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About Anagenics

Anagenics Limited engages in the health, wellness, and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the Pacific Islands. The company was formerly known as Cellmid Limited and changed its name to Anagenics Limited in December 2021. Anagenics Limited was inc...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2004
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AN1

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error